Listed

Organigram Global Inc.: Form 40-F for the period ended Aug 31, 2020

Filed with the SEC on Nov 30, 2020 and accepted by EDGAR at Nov 30, 2020, 13:04 ET.

Share

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-08-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2019-09-01 to 2020-08-31CAD 86.8mifrs-full:Revenue
Cost of revenue12 months2019-09-01 to 2020-08-31CAD 105.0mifrs-full:CostOfSales
Gross profit12 months2019-09-01 to 2020-08-31−CAD 56.5mifrs-full:GrossProfit
Operating income12 months2019-09-01 to 2020-08-31−CAD 145.5mifrs-full:ProfitLossFromOperatingActivities
Net income12 months2019-09-01 to 2020-08-31−CAD 136.2mifrs-full:ProfitLoss
Diluted EPS12 months2019-09-01 to 2020-08-31−CAD 0.79ifrs-full:DilutedEarningsLossPerShare
Basic EPS12 months2019-09-01 to 2020-08-31−CAD 0.79ifrs-full:BasicEarningsLossPerShare
Operating cash flow12 months2019-09-01 to 2020-08-31−CAD 45.1mifrs-full:CashFlowsFromUsedInOperatingActivities
Capital expenditure12 months2019-09-01 to 2020-08-31CAD 77.2mifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
Current assetsAt period end2020-08-31CAD 170.2mifrs-full:CurrentAssets
Total assetsAt period end2020-08-31CAD 435.1mifrs-full:Assets
Current liabilitiesAt period end2020-08-31CAD 29.1mifrs-full:CurrentLiabilities
Total liabilitiesAt period end2020-08-31CAD 135.6mifrs-full:Liabilities
Shareholders' equityAt period end2020-08-31CAD 299.5mifrs-full:Equity
Shares outstandingAt period end2020-08-31156,196,347 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001062993-20-005949. Last ingested by Listed: Nov 3, 2026, 15:22 ET. Listed shows no prices and gives no investment advice.